Laidlaw analyst Yale Jen downgraded MEI Pharma (NASDAQ: MEIP) from Buy to Hold.The analyst comments: "This morning, MEIP reported its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE